• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Imaging and Intervention

Insertion site associated with catheter-related complications: The 3SITES study

byShaidah Deghan, MSc. MD
September 24, 2015
in Imaging and Intervention, Infectious Disease
Reading Time: 2 mins read
Transthoracic echocardiography can rule out endocarditis in low-risk bacteremic patients
Share on FacebookShare on Twitter

 

1. In the three-choice comparison of different catheter insertion sites, the femoral group had a higher incidence of major catheter-related complications compared to the jugular and subclavian catheter insertion site.

2. The frequency of mechanical complications differed based on insertion-site.

Evidence Rating Level: 1 (Excellent)      

Study Rundown: Infectious, thrombotic, and mechanical complications have been associated with central venous catherization of the subclavian, jugular and femoral veins. These complications effect the morbidity, mortality and health care costs of catheter-related blood stream infections. The 3SITES study evaluated the risks of catheter-related bloodstream infection or symptomatic catheter-related deep-vein thrombosis (DVT) for ICU patients. In this randomized, controlled trial, catheterization of the subclavian vein was associated with a significantly reduced risk of the combined outcome of catheter-related bloodstream infection and symptomatic DVT. Subclavian-vein catheterization was associated with a significantly higher risk of mechanical complications such as pneumothorax. In this study the incidence of total DVT should be interpreted with caution due to missing data on 59% of asymptomatic DVT patients.

Click to read the study, published today in NEJM

RELATED REPORTS

The rate of urethrocutaneous fistula formation may be similar between caudal and penile blocks

2 Minute Medicine Rewind October 12, 2026

Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections

Relevant Reading: Complications of Femoral and Subclavian Venous Catheterization in Critically Ill Patients: A Randomized Controlled Trial

In-Depth [randomized controlled trial]: A total of 3027 patients and 3471 catheters were included in the 3SITES study which was a multicenter randomized, controlled trial. Patients were evaluated for all three venous access sites (subclavian, jugular, and femoral). If all catheter insertion sites were suitable for placement the insertion site was assigned in a 1:1:1 randomization. If only two sites were suitable a 1:1 randomization was implemented. The primary outcome was incidence of major catheter-related complications from the time of catheter insertion to 48 hours after catheter removal. Secondary outcomes included the time to catheter-tip colonization and time to total DVT after catheter removal.

There were a total of 50 nonduplicate primary outcomes with 8,20, and 22 primary outcome events occurring in the subclavian, jugular, and femoral groups, respectively. A three-choice comparison of these events showed 1.5, 3.6, and 4.6 events per 1000 catheter-days, respectively (p=0.02). The femoral group had a significantly higher risk of primary outcome compared to the subclavian group (HR = 3.5; 95% [CI], 1.5-7.8; p = 0.003). Furthermore, the jugular group had a significantly higher risk of primary outcomes compared to the subclavian group (HR =2.1; 95% [CI], 1.0-4.3; p=0.04). The risk in the femoral group was similar to that in the jugular group (p=0.3). Major mechanical complications, primarily pneumothorax which required chest-tube insertion, occurred in 1.5% of the subclavian-vein insertions and 0.5% of the jugular-vein insertions.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Previous Post

Letrozole linked to lower rate of multiple gestation and live birth vs gonadotropin: The AMIGOS study

Next Post

MRI reveals evolution of cerebral microhemorrhages in traumatic brain injury

RelatedReports

Imaging and Intervention

The rate of urethrocutaneous fistula formation may be similar between caudal and penile blocks

October 12, 2026
Weekly Rewinds

2 Minute Medicine Rewind October 12, 2026

October 12, 2026
Infectious Disease

Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections

October 9, 2026
2 Minute Medicine

Most routine blood tests do not require prolonged fasting

October 9, 2026
Next Post
MRI reveals evolution of cerebral microhemorrhages in traumatic brain injury

MRI reveals evolution of cerebral microhemorrhages in traumatic brain injury

Active surveillance in favorable-risk prostate cancer associated with low long-term mortality

Active surveillance in favorable-risk prostate cancer associated with low long-term mortality

Lower long-term IUD use among young women

Lower long-term IUD use among young women

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The rate of urethrocutaneous fistula formation may be similar between caudal and penile blocks
  • 2 Minute Medicine Rewind October 12, 2026
  • Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.